These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 12684406

  • 21. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Clin Cancer Res; 2005 Sep 15; 11(18):6582-8. PubMed ID: 16166436
    [Abstract] [Full Text] [Related]

  • 22. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, Epstein JI, Partin AW, Sidransky D.
    Clin Cancer Res; 2005 Dec 01; 11(23):8321-5. PubMed ID: 16322291
    [Abstract] [Full Text] [Related]

  • 23. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma.
    Maruyama R, Sugio K, Yoshino I, Maehara Y, Gazdar AF.
    Cancer; 2004 Apr 01; 100(7):1472-7. PubMed ID: 15042681
    [Abstract] [Full Text] [Related]

  • 24. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
    Nakamichi I, Tomita Y, Zhang B, Sugiyama H, Kanakura Y, Fukuhara S, Hino M, Kanamaru A, Ogawa H, Aozasa K.
    Ann Hematol; 2007 Aug 01; 86(8):557-64. PubMed ID: 17508213
    [Abstract] [Full Text] [Related]

  • 25. Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer.
    Wang J, Lee JJ, Wang L, Liu DD, Lu C, Fan YH, Hong WK, Mao L.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6119-25. PubMed ID: 15447998
    [Abstract] [Full Text] [Related]

  • 26. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
    Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG.
    Cancer Res; 1999 Jan 01; 59(1):67-70. PubMed ID: 9892187
    [Abstract] [Full Text] [Related]

  • 27. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.
    Lee TL, Leung WK, Chan MW, Ng EK, Tong JH, Lo KW, Chung SC, Sung JJ, To KF.
    Clin Cancer Res; 2002 Jun 01; 8(6):1761-6. PubMed ID: 12060614
    [Abstract] [Full Text] [Related]

  • 28. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO, Begum S, Topaloglu O, Jeronimo C, Mambo E, Westra WH, Califano JA, Sidransky D.
    Cancer Res; 2004 Aug 01; 64(15):5511-7. PubMed ID: 15289362
    [Abstract] [Full Text] [Related]

  • 29. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
    Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B.
    Clin Cancer Res; 2005 Mar 15; 11(6):2156-62. PubMed ID: 15788661
    [Abstract] [Full Text] [Related]

  • 30. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
    Vallböhmer D, Brabender J, Yang D, Schneider PM, Metzger R, Danenberg KD, Hölscher AH, Danenberg PV.
    Clin Lung Cancer; 2006 Jul 15; 8(1):39-44. PubMed ID: 16870044
    [Abstract] [Full Text] [Related]

  • 31. Promoter hypermethylation of resected bronchial margins: a field defect of changes?
    Guo M, House MG, Hooker C, Han Y, Heath E, Gabrielson E, Yang SC, Baylin SB, Herman JG, Brock MV.
    Clin Cancer Res; 2004 Aug 01; 10(15):5131-6. PubMed ID: 15297416
    [Abstract] [Full Text] [Related]

  • 32. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y, Kitajima Y, Miyoshi A, Sato K, Kitahara K, Soejima H, Miyazaki K.
    Ann Surg Oncol; 2005 May 01; 12(5):354-63. PubMed ID: 15915369
    [Abstract] [Full Text] [Related]

  • 33. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.
    Usadel H, Brabender J, Danenberg KD, Jerónimo C, Harden S, Engles J, Danenberg PV, Yang S, Sidransky D.
    Cancer Res; 2002 Jan 15; 62(2):371-5. PubMed ID: 11809682
    [Abstract] [Full Text] [Related]

  • 34. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [Abstract] [Full Text] [Related]

  • 35. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, Tavecchio L, Daidone MG, Sozzi G.
    Clin Cancer Res; 2002 Dec 15; 8(12):3782-7. PubMed ID: 12473590
    [Abstract] [Full Text] [Related]

  • 36. Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication.
    Shimamoto T, Ohyashiki JH, Hirano T, Kato H, Ohyashiki K.
    Oncol Rep; 2004 Aug 15; 12(2):389-95. PubMed ID: 15254707
    [Abstract] [Full Text] [Related]

  • 37. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.
    Toyooka S, Maruyama R, Toyooka KO, McLerran D, Feng Z, Fukuyama Y, Virmani AK, Zochbauer-Muller S, Tsukuda K, Sugio K, Shimizu N, Shimizu K, Lee H, Chen CY, Fong KM, Gilcrease M, Roth JA, Minna JD, Gazdar AF.
    Int J Cancer; 2003 Jan 10; 103(2):153-60. PubMed ID: 12455028
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
    Schildhaus HU, Kröckel I, Lippert H, Malfertheiner P, Roessner A, Schneider-Stock R.
    Int J Oncol; 2005 Jun 10; 26(6):1493-500. PubMed ID: 15870861
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.